Clinical Trial Update: Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of cefazolin with ertapenem for methicillin-susceptible Staphylococcus aureus bacteremia is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Sepsis
• Staphylococcus Aureus Bacteremia
• Staphylococcus Aureus Endocarditis
• Staphylococcus Aureus Septicemia

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)
• ERTAPENEM (ertapenem)

Snippet

Sponsor: Todd C. Lee MD MPH FIDSA | Conditions: Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia | Phase 2 | Status: RECRUITING